VIR250417C00012500 Option on Vir Biotechnology

An 'Out of The Money' option on Vir has a strike price that Vir Stock has yet to reach, meaning the option has no intrinsic value. 'Out of The Money' options are usually less costly than 'In The Money' options, making them more desirable to traders with smaller amounts of capital. Some of the uses for Vir Biotechnology's 'Out of The Money' options include buying the options if you expect a big move in Vir Biotechnology's stock. Since 'Out of The Money' options have a lower up-front cost (i.e., no intrinsic value) than 'In The Money' options, buying it is a reasonable choice.

Vir Biotechnology's Option Greeks for the contract ending on 2025-04-17 at a strike price of 12.5 measures the various factors that affect its cost and calculated using a theoretical options pricing model. It helps investors make more informed decisions about whether to trade this option contract or when to trade it. In addition to Vir Biotechnology's option greeks, its implied volatility helps estimate the risk of Vir Biotechnology stock implied by the prices of the options on Vir Biotechnology's stock.

Put options written on Vir Biotechnology grant holders of the option the right to sell a specified amount of Vir Biotechnology at a specified price within a specified time frame. The put buyer has a limited loss and, while not fully unlimited gains, as the price of Vir Stock cannot fall below zero, the put buyer does gain as the price drops. So, purchasing a put option on Vir Biotechnology is like buying insurance aginst Vir Biotechnology's downside shift.

By selling Vir Biotechnology's put option, the investors signal their bearish sentiment. A short position in a put option written on Vir Biotechnology will generally make money when the underlying price is above the strike price. Therefore Vir Biotechnology's put payoff at expiration depends on where the Vir Stock price is relative to the put option strike price. The breakeven price of 13.3 is the critical point that divides the payoff function into two parts. Below the breakeven price, the payoff is dropping and negative (the seller makes a loss). Above the breakeven price, the payoff line is upward sloping as the option payoff increases in proportion to Vir Biotechnology's price. Finally, at the strike price of 12.5, the payoff chart is constant and positive.

Vir Biotechnology's option chain is a display of a range of information that helps investors for ways to trade options on Vir. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Vir. It also shows strike prices and maturity days for a Vir Biotechnology against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.

When running Vir Biotechnology's price analysis, check to measure Vir Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vir Biotechnology is operating at the current time. Most of Vir Biotechnology's value examination focuses on studying past and present price action to predict the probability of Vir Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vir Biotechnology's price. Additionally, you may evaluate how the addition of Vir Biotechnology to your portfolios can decrease your overall portfolio volatility.